Trial brings hope for fertility preservation

Fertility post-chemotherapy can be protected by injections of goserelin, an international study has shown.

Speaking at the COSA 2015 annual scientific meeting in Hobart, Professor Kelly-Anne Phillips described the results of an international trial of the gonadotropin releasing hormone (GnRH) agonist.

The trial of 257 premenopausal women with operable hormone-receptor negative breast cancer